Norges Bank’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.45M | Buy |
+174,820
| New | +$2.45M | ﹤0.01% | 1401 |
|
|
2025
Q1 | – | Sell |
-532,793
| Closed | -$7.42M | – | 127 |
|
|
2024
Q4 | $7.42M | Buy |
+532,793
| New | +$7.42M | ﹤0.01% | 1409 |
|
|
2024
Q3 | – | Sell |
-174,820
| Closed | -$1.63M | – | 130 |
|
|
2024
Q2 | $1.63M | Hold |
174,820
| – | – | ﹤0.01% | 1757 |
|
|
2024
Q1 | $1.73M | Buy |
174,820
+93,808
| +116% | +$930K | ﹤0.01% | 1748 |
|
|
2023
Q4 | $262K | Hold |
81,012
| – | – | ﹤0.01% | 1920 |
|
|
2023
Q3 | $430K | Hold |
81,012
| – | – | ﹤0.01% | 1927 |
|
|
2023
Q2 | $772K | Hold |
81,012
| – | – | ﹤0.01% | 1946 |
|
|
2023
Q1 | $891K | Hold |
81,012
| – | – | ﹤0.01% | 2012 |
|
|
2022
Q4 | $1.2M | Hold |
81,012
| – | – | ﹤0.01% | 2034 |
|
|
2022
Q3 | $1.55M | Buy |
81,012
+19,896
| +33% | +$380K | ﹤0.01% | 1946 |
|
|
2022
Q2 | $1.3M | Hold |
61,116
| – | – | ﹤0.01% | 1940 |
|
|
2022
Q1 | $1.18M | Sell |
61,116
-204,277
| -77% | -$3.93M | ﹤0.01% | 2032 |
|
|
2021
Q4 | $5.5M | Buy |
265,393
+204,277
| +334% | +$4.24M | ﹤0.01% | 1897 |
|
|
2021
Q3 | $1.46M | Hold |
61,116
| – | – | ﹤0.01% | 2102 |
|
|
2021
Q2 | $1.67M | Hold |
61,116
| – | – | ﹤0.01% | 2043 |
|
|
2021
Q1 | $1.77M | Buy |
61,116
+40,000
| +189% | +$1.16M | ﹤0.01% | 2004 |
|
|
2020
Q4 | $594K | Hold |
21,116
| – | – | ﹤0.01% | 2069 |
|
|
2020
Q3 | $619K | Buy |
+21,116
| New | +$619K | ﹤0.01% | 2068 |
|